-
Triacetin, HDACs, and Apoptosis in Glioblastoma
2026-08-13
The 2021 Life Sciences study examined how Triacetin and related acetates affect cell-cycle progression, HDAC gene expression, microRNAs, and mTORC2-associated genes in U87MG glioblastoma cells. Its main contribution is a connected epigenetic and signaling model in which acetate compounds produce distinct cell-cycle responses and may promote apoptosis, while molecular docking offers hypotheses for interactions with HDAC-8, mTOR, and Rictor.
-
Sulfo-NHS-Biotin: From Chemistry to Translation
2026-08-13
Sulfo-NHS-Biotin connects practical aqueous protein labeling with translational decision-making. This article explains its amine-reactive mechanism, evaluates random versus site-specific biotinylation through an IL7 AviTag/BirA study, and provides strategic guidance for surface labeling, affinity capture, immunoprecipitation, and therapeutic protein development.
-
3X (DYKDDDDK) Peptide: Assay Design Guide
2026-08-13
The 3X (DYKDDDDK) Peptide is more than a detection reagent: it is an assay-design tool for connecting FLAG capture, immunodetection, proteomics, and structural biology. This guide explains how epitope accessibility, antibody chemistry, metal sensitivity, and experimental controls determine reliable results.
-
Clodronate Liposomes for Liver I/R Macrophage Studies
2026-08-12
Clodronate Liposomes provide a practical loss-of-function tool for testing whether macrophages drive hepatic ischemia-reperfusion injury or mediate paeoniflorin protection. This guide connects depletion, single-cell discovery, tissue readouts, and route-specific troubleshooting while emphasizing matched PBS liposome controls.
-
Linoleic Acid: Practical Assay Workflow
2026-08-12
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a defined omega-6 fatty acid input for oxidative stress, membrane, erythrocyte, migration, and essential fatty acid deficiency workflows. It is appropriate for solvent-compatible cell and animal study designs, but not for aqueous-only protocols or long-term storage of prepared solutions.
-
PTX3–TLR4/NF-κB–FGF21 Signaling in ONFH
2026-08-11
A 2025 Communications Biology study identifies reduced PTX3 as a mechanistic feature of glucocorticoid-induced osteonecrosis of the femoral head and maps a PTX3–TLR4/NF-κB–FGF21 signaling axis. Patient, cellular, genetic, pharmacological, and downstream-rescue experiments support PTX3 as a regulator of osteogenesis and apoptosis, while also defining the preclinical limits of the proposed intervention.
-
Romidepsin and Acetylation-Driven HCC Vulnerability
2026-08-10
Romidepsin (FK228) links HDAC1/2 inhibition to acetylation-dependent spliceosome control in hepatocellular carcinoma. This article translates the finding into practical assay decisions for epigenetic modulation, DNA-damage studies, and PARP-inhibitor combination research.
-
Biotin-HPDP for Reversible Thiol Labeling
2026-08-09
Biotin-HPDP is a sulfhydryl-reactive biotinylation reagent for selective labeling of accessible protein thiols. Its reversible pyridyl disulfide chemistry supports affinity capture, streptavidin binding assays, and biotin-switch workflows while allowing DTT-mediated release.
-
JNJ-10198409: A PDGF Receptor Assay Framework
2026-08-08
JNJ-10198409 is a potent platelet-derived growth factor receptor inhibitor for dissecting PDGF-driven proliferation and angiogenic signaling. This article presents a mechanism-first assay framework informed by recent phosphorylation research, while clearly separating validated evidence from cross-domain interpretation.
-
Hematoxylin and Eosin Staining Kit Guide
2026-08-07
The Hematoxylin and Eosin Staining Kit provides ready-to-use hematoxylin and eosin solutions for visualizing nuclei, cytoplasm, extracellular matrix, and overall tissue architecture. It is intended for research staining of paraffin-embedded or frozen sections and cytological preparations, but it should not be used as a diagnostic or medical product.
-
Optimizing Cytotoxicity Assays with Doxorubicin (Adriamycin)
2026-08-07
This article addresses persistent challenges in cell viability and cytotoxicity experiments by leveraging the reproducibility and mechanistic clarity of Doxorubicin (Adriamycin) HCl (SKU A1832). Drawing on recent research and robust protocol guidance, it demonstrates how biomedical scientists can enhance assay sensitivity and model cardiotoxicity with confidence.
-
Proteomic Dissection of Platycodin D-Induced Apoptosis in NS
2026-08-06
This study delineates how Platycodin D triggers apoptosis in non-small cell lung cancer by targeting RFC4, leading to Notch pathway inhibition. Multidimensional proteomics and biochemical assays provide mechanistic insight, suggesting new avenues for epigenetic and apoptotic intervention in NSCLC.
-
Trametinib (GSK1120212): Precision MEK Inhibition for Transl
2026-08-06
Explore how Trametinib (GSK1120212) empowers oncology and stem cell researchers to dissect MEK-ERK pathway dynamics, confront tumor heterogeneity, and design translationally relevant experiments. This thought-leadership article integrates mechanistic insights, actionable protocol guidance, and emerging research—including new findings linking DNA repair factors like APEX2 to telomerase regulation—to provide a strategic roadmap for next-generation translational studies.
-
PPACK Dihydrochloride: Redefining Precision in Thrombin Inhi
2026-08-05
Explore the advanced biochemical mechanisms and research applications of PPACK Dihydrochloride, a potent inhibitor of thrombin. This article offers a unique, in-depth analysis of its role in dissecting platelet function and blood coagulation pathways.
-
Gamma-linolenic Acid (GLA): Immunometabolic Insights for Inf
2026-08-05
Explore the multifaceted role of Gamma-linolenic acid (GLA) as an omega-6 fatty acid in immunometabolic and anti-inflammatory research. This article uniquely bridges molecular mechanisms, translational relevance, and the latest advances in humoral immunity.
451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page